Success Metrics

Clinical Success Rate
88.1%

Based on 74 completed trials

Completion Rate
88%(74/84)
Active Trials
2(2%)
Results Posted
14%(10 trials)
Terminated
10(9%)

Phase Distribution

Ph phase_4
2
2%
Ph phase_2
10
9%
Ph phase_1
6
6%
Ph not_applicable
50
46%
Ph phase_3
11
10%

Phase Distribution

6

Early Stage

10

Mid Stage

13

Late Stage

Phase Distribution79 total trials
Phase 1Safety & dosage
6(7.6%)
Phase 2Efficacy & side effects
10(12.7%)
Phase 3Large-scale testing
11(13.9%)
Phase 4Post-market surveillance
2(2.5%)
N/ANon-phased studies
50(63.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

74 of 91 finished

Non-Completion Rate

18.7%

17 ended early

Currently Active

2

trials recruiting

Total Trials

108

all time

Status Distribution
Active(2)
Completed(74)
Terminated(17)
Other(15)

Detailed Status

Completed74
unknown15
Terminated10
Withdrawn7
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
108
Active
2
Success Rate
88.1%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (7.6%)
Phase 210 (12.7%)
Phase 311 (13.9%)
Phase 42 (2.5%)
N/A50 (63.3%)

Trials by Status

terminated109%
unknown1514%
active_not_recruiting22%
completed7469%
withdrawn76%

Recent Activity

Clinical Trials (108)

Showing 20 of 108 trialsScroll for more
NCT02387905Phase 2

Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases

Active Not Recruiting
NCT01721343Not Applicable

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

Completed
NCT01199562

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Active Not Recruiting
NCT00466830

Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer

Withdrawn
NCT01393821Not Applicable

Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab

Completed
NCT01660347Not Applicable

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Withdrawn
NCT00930332Phase 1

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Terminated
NCT00577317Phase 3

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Terminated
NCT00007007Not Applicable

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Completed
NCT02192333Not Applicable

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Completed
NCT00258401Not Applicable

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Completed
NCT01347723

Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy

Completed
NCT00004234Phase 3

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Completed
NCT01867294Phase 2

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Completed
NCT01799031Not Applicable

Educational Intervention for Reducing Work Disability in Breast Cancer Survivors

Completed
NCT00735514

Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer

Completed
NCT01243541Not Applicable

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Terminated
NCT01140282Not Applicable

Exercise Program for Early Breast Cancer Survivors

Completed
NCT01116232Phase 2

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Terminated
NCT00372450Not Applicable

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Withdrawn

Drug Details

Intervention Type
PROCEDURE
Total Trials
108